Pharma M&A and VC activity declines in March 2025, reports GlobalData
GlobalData data shows a 46.9% drop in deal value and a 21.4% decline in venture capital investments year-on-year
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma M&A
Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT
The Company expects to complete the amalgamation process by Q1FY26
DKSH Technology Acquires Taqkey Science and Quantum Biotech, two technology distribution companies…
DKSH has signed an agreement to acquire Taqkey Science and Quantum Biotech in Taiwan. With these transactions, DKSH Technology…
Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025
Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…
Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023
Three major deals contributed 70 per cent of the total deal value during December 2024
Pharma CMO M&A activity shifts focus to scaling in 2023: GlobalData
High inflation and interest rates along with an uncertain business environment have disincentivised investment. The focus shifts…
Veeda Clinical Research acquires Heads, a European CRO
Veeda expands its reach to major geographies and adds capabilities of late-stage clinical trial execution with strong focus on…
Akums’ acquires new formulation facility in Baddi
It is slated to become operational in the year 2024
India Pharma Inc in M&A mode once again
While the big names are in the news, we could see a similar consolidation among pharma MSMEs which might not hit the headlines
Amneal Pharma acquires injectable firm Punishka Healthcare for Rs 700 crores
The acquisition significantly enhances Amneal’s injectables manufacturing infrastructure, capabilities, and capacity to support…